CellCentric
Cambridge, England, United Kingdom · Biotechnology, Health Care, Manufacturing
CellCentric is a clinical-stage biotechnology company advancing Inobrodib, a new treatment for cancer, particularly multiple myeloma. This small molecule drug targets p300/CBP, reducing the expression of key cancer drivers, MYC and IRF4. It is delivered as an oral capsule, allowing patients to use it at home without the need for intensive monitoring. The drug has a favorable safety profile, making
Key facts
- Headquarters
- Cambridge, England, United Kingdom
- Employees
- 52
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Private
- Website
- www.cellcentric.com
- Company page
Recent activity at CellCentric
- : cellcentric Appoints Lars Ljungström as Chief Financial Officer
- : Toyota Becomes Equal Partner in Fuel Cell Company Cellcentric Alongside Volvo and Daimler Truck.
- : CellCentric completes $220 million Series D financing led by Venrock Healthcare to advance inobrodib trials for multiple myeloma.
- : cellcentric Appoints Kai Woerner as Chief Operating Officer
- : CellCentric raises $120M in Series C funding, led by RA Capital Management and Forbion. The funds will advance Inobrodib, a new treatment for cancer and multiple myeloma.
CellCentric funding history
| Date | Round | Amount |
|---|---|---|
| May 2026 | Series D | $220.0M |
| May 2025 | Series C | $120.0M |
Leadership
- Lars Ljungström, Director
- Kai Woerner, Chief Operating Officer
- Naseer Qayum, Chief Strategy Officer
- Tomasz Knurowski, Chief Medical Officer
- Will West, Chief Executive Officer
Verified email and direct lines for CellCentric’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
CellCentric in the news
- CellCentric Announces Oversubscribed $220 Million Series D Financing to Advance Pivotal Trials of Inobrodib in Multiple Myeloma - Business Wire (May 06, 2026)
- CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine - BioPharma Dive (May 06, 2026)
- Toyota, Volvo Group and Daimler Truck AG sign binding agreement for Toyota to join cellcentric as equal shareholder - トヨタ自動車株式会社 公式企業サイト (Jul 27, 2026)
- Daimler Truck, Volvo Group and Toyota Motor Corporation sign binding agreement for Toyota to join cellcentric as equal shareholder - Daimler Truck (Nov 04, 2026)
- Volvo Group and Daimler Truck AG fully committed to hydrogen-based fuel-cells – launch of new joint venture cellcentric - Volvo Group (Apr 29, 2021)
- Toyota Motor Corporation aims to join Daimler Truck and Volvo Group as equal shareholder in the fuel cell joint venture cellcentric - トヨタ自動車株式会社 公式企業サイト (Mar 31, 2026)
- Obesity accelerates hair thinning by stem cell-centric converging mechanisms - Nature (Jun 23, 2021)
- Daimler Truck AG and the Volvo Group complete creation of fuel-cell joint venture: cellcentric - Daimler Truck (Dec 04, 2023)
Companies similar to CellCentric
- Cornerstone Robotics · Biotechnology, Health Care, Manufacturing
- Encision · Biotechnology, Health Care, Manufacturing
- Nyxoah · Biotechnology, Health Care, Manufacturing
- Medec · Biotechnology, Health Care, Manufacturing
- Anja Health · Biotechnology, Health Care, Manufacturing
About CellCentric: questions and answers
What does CellCentric do?
CellCentric is a clinical-stage biotechnology company advancing Inobrodib, a new treatment for cancer, particularly multiple myeloma. This small molecule drug targets p300/CBP, reducing the expression of key cancer drivers, MYC and IRF4. It is delivered as an oral capsule, allowing patients to use it at home without the need for intensive monitoring. The drug has a favorable safety profile, making
Where is CellCentric headquartered?
CellCentric is headquartered in Cambridge, England, United Kingdom.
How many employees does CellCentric have?
CellCentric has about 52 employees.
Has CellCentric raised funding?
Yes. Fundz has recorded 2 funding events for CellCentric. The most recent, Series D of $220.0M, was in May 2026.
Who leads CellCentric?
Will West is a Chief Executive Officer at CellCentric.
What is the latest news on CellCentric?
On Aug 03, 2026, cellcentric Appoints Lars Ljungström as Chief Financial Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy